FDA Drug Application (021880) for REVLIMID by CELGENE

Back to FDA Applications sponsored by CELGENE

Application Number021880
Product Number001
FormCAPSULE;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameREVLIMID
Active IngredientLENALIDOMIDE



Back to FDA Applications sponsored by CELGENE